New options for uveitis treatment. - Wikidata - wikimedia - TriplyDB

New options for uveitis treatment.

New options for uveitis treatment.

http://www.wikidata.org/entity/Q37256887

about

Pharmacotherapy for uveitis: current management and emerging therapy.Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation.

P2860

Q34274075-B28AEBB7-BD8F-4186-BAFC-F0E6A7F8F374 Q36369061-CC9E2C0D-1789-4C90-B9A8-CEAC7DAD2116

P2860

New options for uveitis treatment.

http://www.wikidata.org/entity/Q37256887

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New options for uveitis treatment.

@en

New options for uveitis treatment.

@nl

type

label

New options for uveitis treatment.

@en

New options for uveitis treatment.

@nl

prefLabel

New options for uveitis treatment.

@en

New options for uveitis treatment.

@nl

P1433

Q37256887-1EEABEDB-226A-4C19-AD2D-4355FBC336E0

P1476

Q37256887-F8263B9C-E80D-41D5-8742-74A43520A5AF

P2093

Q37256887-05CE2C0E-4A94-417D-8B9D-0B784BBC5AA7

Q37256887-4973447A-CDF2-4518-856B-8257F59B7648

Q37256887-6C8247D8-8B36-4D45-BAC1-9B8B42E05235

Q37256887-6D89DF78-218E-4D61-AABD-71DFA5B410FE

P2860

Q37256887-04AF9998-11EF-447F-BA10-C7C77EC8A180

Q37256887-04C12985-8CBE-4D43-8754-EB5BF9E6F4CE

Q37256887-0C13D174-275B-46D6-A295-F86DC28184DF

Q37256887-0CF099B1-0FE3-416A-A3E9-53BBE71CE7C1

Q37256887-0F94454C-F071-4444-8717-430576E0D53E

Q37256887-1257628C-0298-40DC-A43A-9E0B1861326B

Q37256887-17DF5412-692F-4F14-BF00-2988BF9B221C

Q37256887-1B85CA90-A3AB-4023-ACF9-89001E76D17E

Q37256887-27058414-E528-4E52-B324-9A7EF882D0E7

Q37256887-2A76BC5F-7410-45B5-8AD3-C812119CCB57

P304

Q37256887-D2BB2B20-6472-471E-9F19-14A03A7EB5B7

P31

Q37256887-59747376-D075-4719-936A-37D263142D71

P356

Q37256887-680D994C-0287-4DF2-B2B0-57A24FDDEC28

P433

Q37256887-1241CCAE-46ED-48E4-B04B-3411616A1E31

P478

Q37256887-E2EED8DF-96C0-42E1-A0BE-D7B8BD90522C

P577

Q37256887-64A48D68-DFB2-4008-BE6B-9C21A953A3A7

P698

Q37256887-3B4B3388-307E-4139-9BD8-4C50694F1537

P921

Q37256887-82CB4457-6298-4543-A47E-09790D19C632

P932

Q37256887-F39D52F0-FFDB-4A67-8BF8-C74EC03FC72A

P356

J.ISSN.2222-3959.2013.05.29

P1433

International Journal of Ophthalmology

P1476

New options for uveitis treatment.

@en

P2093

Jing-Ming Shi

http://www.w3.org/2001/XMLSchema#string

Song-Bai Jia

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Yu He

http://www.w3.org/2001/XMLSchema#string

P2860

Strategies for silencing human disease using RNA interference

Cyclosporine for ocular inflammatory diseases.

Mycophenolate mofetil for ocular inflammation.

Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitis

AAV2-mediated subretinal gene transfer of hIFN-α attenuates experimental autoimmune uveoretinitis in mice.

AAV2-mediated subretinal gene transfer of mIL-27p28 attenuates experimental autoimmune uveoretinitis in mice

AAV2-mediated combined subretinal delivery of IFN-α and IL-4 reduces the severity of experimental autoimmune uveoretinitis

A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.

Treatment of retinal vasculitis in Behçet's disease with rituximab.

Republished review: Gene therapy for ocular diseases.

P304

702-707

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3980/J.ISSN.2222-3959.2013.05.29

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24195053

http://www.w3.org/2001/XMLSchema#string

P921

P932

3808925

http://www.w3.org/2001/XMLSchema#string